Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

As you can see below, at the end of June 2024, Pfizer had US$69.9b of debt, up from US$65.7b a year ago. Click the image for ...

PFE's non-COVID drugs and potential contribution from new and newly acquired products have started to drive growth.

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

State Surgeon General Joseph Ladapo spread anti-vaccine misinformation by telling Floridians to avoid mRNA vaccines. Vaccine ...

New treatment builds on Pfizer’s migraine portfolio to further meet the needs of people living with this debilitating disease ...

Providing a diverse range of perspectives from bullish to bearish, 13 analysts have published ratings on Pfizer PFE in the ...

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

Inspired by Pfizer’s response to the COVID pandemic, Miguel Agreda ’25 brought his skills as a joint-degree MBA/MPH student ...

Pharma giant Pfizer said that a drug aimed at helping cancer patients losing appetite and muscle mass showed positive results ...